caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · Loading…
caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1518939537

Adam BrufskyMD

Medical OncologyPittsburgh, PAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$326K
Payment records
224
By payment type
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$136K
Consulting Fee$129K
Travel and Lodging$50K
Honoraria$6K
Food and Beverage$4K
REFERRAL NETWORK

Where Adam Brufsky's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Christiane Hakim
Diagnostic Radiology · Pittsburgh, PA
2046
Shannon Huggins-Puhalla
Medical Oncology · Pittsburgh, PA
1971
Grace Rathfon
Diagnostic Radiology · Pittsburgh, PA
1346
Kathryn Berlacher
Cardiology · Pittsburgh, PA
1117
UPMC PASSAVANT1146
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
1,035
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
17
Brand share
12.7%
Top prescribed drugs
Anastrozole394 claims
Letrozole184 claims
Tamoxifen Citrate97 claims
Exemestane62 claims
Palbociclib59 claims
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
225
Unique beneficiaries
—
Total services
364
Distinct HCPCS
4
Medicare payment
$25K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 199 Medical Oncology providers in PA — below median (cohort median 620).